TVTX·89422G107·US·equity·Healthcare - Biotechnology-13D/G
TVTX (TRAVERE THERAPEUTICS INC) is held by 145 institutional investors as of Q1 2026. Largest holders: JANUS HENDERSON GROUP PLC ($339.2M), FMR LLC ($325.9M), BlackRock, Inc. ($231.5M). Net institutional sentiment: Mixed.
See how TVTX's score breaks down across 4 SEC sources
Showing 1-20 of 163
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer